{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:43:38Z","timestamp":1790729018485,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03070-2","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T18:52:46Z","timestamp":1741200766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dual Drug Loaded Topical Cubosomal Gel Against Candida Albicans: An In Vitro and In Vivo Proof of Concept"],"prefix":"10.1208","volume":"26","author":[{"given":"A. Gowri","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudi K.","family":"Vaiphei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sargun","family":"Basrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanjan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep K.","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-8125","authenticated-orcid":false,"given":"Arvind","family":"Gulbake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"3070_CR1","doi-asserted-by":"crossref","unstructured":"Shahid M, Hussain A, Khan AA, Alanazi AM, Alaofi AL, Alam M et al. Antifungal cationic nanoemulsion ferrying miconazole nitrate with synergism to control fungal infections: in vitro, ex vivo, and in vivo evaluations. ACS Omega. 2022;7(15):13343\u201353.","DOI":"10.1021\/acsomega.2c01075"},{"key":"3070_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jddst.2018.12.014","volume":"49","author":"MM AbouSamra","year":"2019","unstructured":"AbouSamra MM, Basha M, Awad GEA, Mansy SS. A promising nystatin nanocapsular hydrogel as an antifungal polymeric carrier for the treatment of topical candidiasis. J Drug Del Sci Technol. 2019;49:365\u201374.","journal-title":"J Drug Del Sci Technol"},{"issue":"1","key":"3070_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jof6010023","volume":"6","author":"SB Salazar","year":"2020","unstructured":"Salazar SB, Sim\u00f5es RS, Pedro NA, Pinheiro MJ, Carvalho M, Mira NP. An overview on conventional and non-conventional therapeutic approaches for the treatment of candidiasis and underlying resistance mechanisms in clinical strains. J Fungi (Basel). 2020;6(1):23.","journal-title":"J Fungi (Basel)."},{"key":"3070_CR4","doi-asserted-by":"publisher","first-page":"104953","DOI":"10.1016\/j.chemphyslip.2020.104953","volume":"232","author":"N Dudhipala","year":"2020","unstructured":"Dudhipala N, Ay AA. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections. Chem Phys Lipids. 2020;232:104953.","journal-title":"Chem Phys Lipids"},{"issue":"Pt A","key":"3070_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ijbiomac.2016.09.042","volume":"93","author":"S Kumar","year":"2016","unstructured":"Kumar S, Kaur P, Bernela M, Rani R, Thakur R. Ketoconazole encapsulated in chitosan-gellan gum nanocomplexes exhibits prolonged antifungal activity. Int J Biol Macromol. 2016;93(Pt A):988\u201394.","journal-title":"Int J Biol Macromol"},{"key":"3070_CR6","doi-asserted-by":"publisher","first-page":"101574","DOI":"10.1016\/j.jddst.2020.101574","volume":"56","author":"SK Sadozai","year":"2020","unstructured":"Sadozai SK, Khan SA, Karim N, Becker D, Steinbr\u00fcck N, Gier S, et al. Ketoconazole-loaded PLGA nanoparticles and their synergism against Candida albicans when combined with silver nanoparticles. J Drug Del Sci Technol. 2020;56:101574.","journal-title":"J Drug Del Sci Technol"},{"issue":"7","key":"3070_CR7","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s13346-021-01058-6","volume":"12","author":"M Ramzan","year":"2022","unstructured":"Ramzan M, Gourion-Arsiquaud S, Hussain A, Gulati JS, Zhang Q, Trehan S, et al. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery. Drug Deliv Transl Res. 2022;12(7):1659\u201383.","journal-title":"Drug Deliv Transl Res"},{"key":"3070_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jddst.2018.07.007","volume":"47","author":"N Tiwari","year":"2018","unstructured":"Tiwari N, Sivakumar A, Mukherjee A, Chandrasekaran N. Enhanced antifungal activity of Ketoconazole using rose oil based novel microemulsion formulation. J Drug Del Sci Technol. 2018;47:434\u201344.","journal-title":"J Drug Del Sci Technol"},{"issue":"31","key":"3070_CR9","doi-asserted-by":"publisher","first-page":"28233","DOI":"10.1021\/acsomega.3c01571","volume":"8","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Farheen M, Kukreti A, Afzal O, Akhter MH, Chitme H, et al. Natural oils enhance the topical delivery of ketoconazole by nanoemulgel for fungal infections. ACS Omega. 2023;8(31):28233\u201348.","journal-title":"ACS Omega"},{"key":"3070_CR10","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1039\/D4NA00176A","volume":"6","author":"P Dubey","year":"2024","unstructured":"Dubey P, Kumar A, Vaiphei K, Basrani S, Jadhav A, Wilen C-E, et al. Poly-\u03b4-decalactone (PDL) based nanoemulgel for topical delivery of ketoconazole and eugenol against Candida albicans. Nanoscale Adv. 2024;6:5322\u201336.","journal-title":"Nanoscale Adv."},{"issue":"1","key":"3070_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41598-020-58256-4","volume":"10","author":"SA Lone","year":"2020","unstructured":"Lone SA, Wani MY, Fru P, Ahmad A. Cellular apoptosis and necrosis as therapeutic targets for novel Eugenol Tosylate Congeners against Candida albicans. Sci Rep. 2020;10(1):1191.","journal-title":"Sci Rep"},{"key":"3070_CR12","doi-asserted-by":"publisher","first-page":"872127","DOI":"10.3389\/fphar.2022.872127","volume":"13","author":"M Didehdar","year":"2022","unstructured":"Didehdar M, Chegini Z, Shariati A. Eugenol: A novel therapeutic agent for the inhibition of Candida species infection. Front Pharmacol. 2022;13:872127.","journal-title":"Front Pharmacol"},{"key":"3070_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/0972060X.2007.10643575","volume":"10","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Jirovetz L, Wlcek K, Buchbauer G, Gochev V, Girova T, et al. Antifungal activity of eugenol and various eugenol-containing essential oils against 38 clinical isolates of Candida albicans. J Essen Oil Bear Plants. 2013;10:421\u20139.","journal-title":"J Essen Oil Bear Plants"},{"issue":"1","key":"3070_CR14","doi-asserted-by":"publisher","first-page":"2162159","DOI":"10.1080\/10717544.2022.2162159","volume":"30","author":"HA Elgendy","year":"2023","unstructured":"Elgendy HA, Makky AMA, Elakkad YE, Ismail RM, Younes NF. Syringeable atorvastatin loaded eugenol enriched PEGylated cubosomes in-situ gel for the intra-pocket treatment of periodontitis: statistical optimization and clinical assessment. Drug Deliv. 2023;30(1):2162159.","journal-title":"Drug Deliv"},{"key":"3070_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02652048.2023.2244094","volume":"40","author":"CL Putta","year":"2023","unstructured":"Putta CL, Rahman SNR, Chakraborty P, Shunmugaperumal T. Development, systematic optimisation and biofilm disruption activity of eugenol-based nanosized emulsions stabilised with Tween 80. J Microencapsul. 2023;40:1\u201317.","journal-title":"J Microencapsul."},{"issue":"2","key":"3070_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/jof7020079","volume":"7","author":"J Talapko","year":"2021","unstructured":"Talapko J, Juzba\u0161i\u0107 M, Matijevi\u0107 T, Pustijanac E, Beki\u0107 S, Kotris I, et al. Candida albicans-the virulence factors and clinical manifestations of infection. J Fungi. 2021;7(2):79.","journal-title":"J Fungi"},{"key":"3070_CR17","first-page":"12037","volume":"11","author":"AK Chettupalli","year":"2021","unstructured":"Chettupalli AK, Ananthula M, Amarachinta PR, Bakshi V, Yata VK. Design, Formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointerface Res Appl Chem. 2021;11:12037\u201354.","journal-title":"Biointerface Res Appl Chem"},{"key":"3070_CR18","doi-asserted-by":"publisher","first-page":"111548","DOI":"10.1016\/j.msec.2020.111548","volume":"119","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Banerjee S, Khan S, Jha PN, Gupta G, Dua K, et al. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater Sci Eng C Mater Biol Appl. 2021;119:111548.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"3070_CR19","doi-asserted-by":"publisher","first-page":"2683466","DOI":"10.1155\/2024\/2683466","volume":"2024","author":"AG Nath","year":"2024","unstructured":"Nath AG, Dubey P, Kumar A, Vaiphei KK, Rosenholm JM, Bansal KK, et al. Recent advances in the use of cubosomes as drug carriers with special emphasis on topical applications. J Lipids. 2024;2024(1):2683466.","journal-title":"J Lipids"},{"issue":"4","key":"3070_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/1061186X.2017.1367006","volume":"26","author":"RR Wakaskar","year":"2018","unstructured":"Wakaskar RR. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. J Drug Target. 2018;26(4):311\u20138.","journal-title":"J Drug Target"},{"key":"3070_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.addr.2021.01.006","volume":"172","author":"MJ Webber","year":"2021","unstructured":"Webber MJ, Pashuck ET. (Macro)molecular self-assembly for hydrogel drug delivery. Adv Drug Deliv Rev. 2021;172:275\u201395.","journal-title":"Adv Drug Deliv Rev"},{"key":"3070_CR22","doi-asserted-by":"crossref","unstructured":"Kumar A, Panwar D, Bhavana V, Thakor P, Singh PK, Mehra NK. Lipid-based nanomaterials: a brief note on composition, development, and drug delivery applications. Nanomaterial-based drug delivery systems: therapeutic and theranostic applications: Springer; 2023;p. 65\u201398.","DOI":"10.1007\/978-3-031-30529-0_3"},{"key":"3070_CR23","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.jddst.2022.103503","volume":"74","author":"A Kumar","year":"2022","unstructured":"Kumar A, Valamla B, Thakor P, Chary PS, Rajana N, Mehra NK. Development and evaluation of nanocrystals loaded hydrogel for topical application. J Drug Del Sci Technol. 2022;74:103503.","journal-title":"J Drug Del Sci Technol"},{"key":"3070_CR24","doi-asserted-by":"crossref","unstructured":"Kumar R. Chapter 8 - Lipid-based nanoparticles for drug-delivery systems. In: Mohapatra SS, Ranjan S, Dasgupta N, Mishra RK, Thomas S, editors. Nanocarriers for Drug Delivery: Elsevier; 2019. p. 249\u201384.","DOI":"10.1016\/B978-0-12-814033-8.00008-4"},{"key":"3070_CR25","doi-asserted-by":"publisher","first-page":"122665","DOI":"10.1016\/j.ijpharm.2023.122665","volume":"634","author":"A Makhlouf","year":"2023","unstructured":"Makhlouf A, Elnawawy T. Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging. Int J Pharm. 2023;634:122665.","journal-title":"Int J Pharm"},{"issue":"36","key":"3070_CR26","doi-asserted-by":"publisher","first-page":"20438","DOI":"10.1021\/acsami.5b06413","volume":"7","author":"DH Kim","year":"2015","unstructured":"Kim DH, Lim S, Shim J, Song JE, Chang JS, Jin KS, et al. A simple evaporation method for large-scale production of liquid crystalline lipid nanoparticles with various internal structures. ACS Appl Mater Interfaces. 2015;7(36):20438\u201346.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3070_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jddst.2016.06.011","volume":"35","author":"M Nasr","year":"2016","unstructured":"Nasr M, Dawoud M. Sorbitol based powder precursor of cubosomes as an oral delivery system for improved bioavailability of poorly water soluble drugs. J Drug Del Sci Technol. 2016;35:106\u201313.","journal-title":"J Drug Del Sci Technol"},{"key":"3070_CR28","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.chemphyslip.2020.105028","volume":"234","author":"A Mahmood","year":"2021","unstructured":"Mahmood A, Rapalli VK, Waghule T, Gorantla S, Singhvi G. Luliconazole loaded lyotropic liquid crystalline nanoparticles for topical delivery: QbD driven optimization, in-vitro characterization and dermatokinetic assessment. Chem Phys Lipids. 2021;234:105028.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"3070_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s43094-023-00561-6","volume":"9","author":"A Kumar","year":"2023","unstructured":"Kumar A, Jat S, Kumar P, Gulbake A. QbD-driven RP-HPLC method for novel chemo-herbal combination, in-silico, force degradation studies, and characterization of dual drug-loaded polymeric and lipidic nanocarriers. Future J Pharm Sci. 2023;9(1):110.","journal-title":"Future J Pharm Sci"},{"issue":"3","key":"3070_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.xphs.2023.11.031","volume":"113","author":"SN Chilamakuri","year":"2024","unstructured":"Chilamakuri SN, Kumar A, Nath AG, Gupta A, Selvaraju S, Basrani S, et al. Development and in-vitro evaluation of eugenol-based nanostructured lipid carriers for effectual topical treatment against C. albicans. J Pharm Sci. 2024;113(3):772\u201384.","journal-title":"J Pharm Sci."},{"key":"3070_CR31","doi-asserted-by":"publisher","first-page":"121082","DOI":"10.1016\/j.ijpharm.2021.121082","volume":"608","author":"Q Tian","year":"2021","unstructured":"Tian Q, Quan P, Fang L, Xu H, Liu C. A molecular mechanism investigation of the transdermal\/topical absorption classification system on the basis of drug skin permeation and skin retention. Int J Pharm. 2021;608:121082.","journal-title":"Int J Pharm"},{"key":"3070_CR32","doi-asserted-by":"publisher","first-page":"106508","DOI":"10.1016\/j.ejps.2023.106508","volume":"188","author":"ADR Teixeira","year":"2023","unstructured":"Teixeira ADR, Quaresma AV, Branquinho RT, Santos S, Magalh\u00e3es JT, Silva F, et al. Miconazole-loaded nanoparticles coated with hyaluronic acid to treat vulvovaginal candidiasis. Eur J Pharm Sci. 2023;188:106508.","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"3070_CR33","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1080\/03639045.2016.1188110","volume":"42","author":"RL Pereira","year":"2016","unstructured":"Pereira RL, Leites FI, Paese K, Sponchiado RM, Michalowski CB, Guterres SS, et al. Hydrogel containing adapalene- and dapsone-loaded lipid-core nanocapsules for cutaneous application: development, characterization, in vitro irritation and permeation studies. Drug Dev Ind Pharm. 2016;42(12):2001\u20138.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"3070_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jam.14949","volume":"131","author":"R Pereira","year":"2021","unstructured":"Pereira R, Dos Santos Fontenelle RO, de Brito EHS, de Morais SM. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol. 2021;131(1):11\u201322.","journal-title":"J Appl Microbiol"},{"issue":"1","key":"3070_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00284-023-03542-3","volume":"81","author":"SB Patil","year":"2023","unstructured":"Patil SB, Sharma RK, Gavandi TC, Basrani ST, Chougule SA, Yankanchi SR, et al. Ethyl Isothiocyanate as a novel antifungal agent against Candida albicans. Curr Microbiol. 2023;81(1):29.","journal-title":"Curr Microbiol"},{"issue":"2","key":"3070_CR36","first-page":"29","volume":"9","author":"S Balasaheb Patil","year":"2023","unstructured":"Balasaheb Patil S, Khanderao Jadhav A, Kumar Sharma R, Tushar Basrani S, Chandsaheb Gavandi T, Ashok Chougule S, et al. Antifungal activity of Allyl isothiocyanate by targeting signal transduction pathway, ergosterol biosynthesis, and cell cycle in Candida albicans. Curr Med Mycol. 2023;9(2):29\u201338.","journal-title":"Curr Med Mycol"},{"issue":"1\u20132","key":"3070_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijpharm.2015.07.036","volume":"493","author":"Q Luo","year":"2015","unstructured":"Luo Q, Lin T, Zhang CY, Zhu T, Wang L, Ji Z, et al. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake. Int J Pharm. 2015;493(1\u20132):30\u20139.","journal-title":"Int J Pharm"},{"issue":"6","key":"3070_CR38","doi-asserted-by":"publisher","first-page":"51612","DOI":"10.1002\/app.51612","volume":"139","author":"S Yakaew","year":"2022","unstructured":"Yakaew S, Luangpradikun K, Phimnuan P, Nuengchamnong N, Kamonsutthipaijit N, Rugmai S, et al. Investigation into poloxamer 188-based cubosomes as a polymeric carrier for poor water-soluble actives. J Appl Polym Sci. 2022;139(6):51612.","journal-title":"J Appl Polym Sci"},{"issue":"4","key":"3070_CR39","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1208\/s12249-012-9876-2","volume":"13","author":"Z Yang","year":"2012","unstructured":"Yang Z, Tan Y, Chen M, Dian L, Shan Z, Peng X, et al. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech. 2012;13(4):1483\u201391.","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"3070_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/10610278.2019.1702663","volume":"31","author":"Z Yang","year":"2019","unstructured":"Yang Z, Chai Y, Zhou D, Yao X, Ji H. Mechanism for efficient separation of eugenol and eugenol acetate with \u03b2-cyclodextrin as a selective solvent. Supramol Chem. 2019;31(12):767\u201375.","journal-title":"Supramol Chem"},{"issue":"1","key":"3070_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.apsb.2014.12.001","volume":"5","author":"M Nasr","year":"2015","unstructured":"Nasr M, Ghorab MK, Abdelazem A. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B. 2015;5(1):79\u201388.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"3070_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","volume":"47","author":"G-H Son","year":"2017","unstructured":"Son G-H, Lee B-J, Cho C-W. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J Pharm Investig. 2017;47(4):287\u201396.","journal-title":"J Pharm Investig"},{"key":"3070_CR43","doi-asserted-by":"crossref","unstructured":"Shiehzadeh F, Mohebi D, Chavoshian O, Daneshmand S. Formulation, characterization, and optimization of a topical gel containing tranexamic acid to prevent superficial bleeding: in vivo and in vitro evaluations. Turk J Pharm Sci. 2023;20(4):261\u20139.","DOI":"10.4274\/tjps.galenos.2022.60687"},{"key":"3070_CR44","doi-asserted-by":"publisher","first-page":"1359219","DOI":"10.3389\/fnano.2024.1359219","volume":"6","author":"C Zhu","year":"2024","unstructured":"Zhu C, Duan W, Jing H, Long J, Huang Y, Huang D, et al. Improving the stability and transdermal permeability of phycocyanin loaded cubosomes. Front Nanotechnol. 2024;6:1359219.","journal-title":"Front Nanotechnol"},{"issue":"8","key":"3070_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1208\/s12249-020-01863-1","volume":"21","author":"ACS Oliveira","year":"2020","unstructured":"Oliveira ACS, Oliveira PM, Cunha-Filho M, Gratieri T, Gelfuso GM. Latanoprost loaded in polymeric nanocapsules for effective topical treatment of Alopecia. AAPS PharmSciTech. 2020;21(8):305.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3070_CR46","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/pharmaceutics13081241","volume":"13","author":"LA Balestrin","year":"2021","unstructured":"Balestrin LA, Kreutz T, Fachel FNS, Bidone J, Gelsleichter NE, Koester LS, et al. Achyrocline satureioides (Lam.) DC (Asteraceae) Extract-loaded nanoemulsions as a promising topical wound healing delivery system: in vitro assessments in human keratinocytes (HaCaT) and HET-CAM Irritant Potential. Pharmaceutics. 2021;13(8):1241.","journal-title":"Pharmaceutics."},{"key":"3070_CR47","doi-asserted-by":"publisher","first-page":"1400881","DOI":"10.3389\/fchem.2024.1400881","volume":"12","author":"N Ruscinc","year":"2024","unstructured":"Ruscinc N, Massarico Serafim RA, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Front Chem. 2024;12:1400881.","journal-title":"Front Chem"},{"issue":"7","key":"3070_CR48","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/myc.13276","volume":"64","author":"B da Costa","year":"2021","unstructured":"da Costa B, Pippi B, Berlitz SJ, Carvalho AR, Teixeira ML, K\u00fclkamp-Guerreiro IC, et al. Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis. Mycoses. 2021;64(7):727\u201333.","journal-title":"Mycoses"},{"issue":"3","key":"3070_CR49","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.mycmed.2020.101003","volume":"30","author":"EH Endo","year":"2020","unstructured":"Endo EH, Makimori RY, Companhoni MVP, Ueda-Nakamura T, Nakamura CV, Dias Filho BP. Ketoconazole-loaded poly-(lactic acid) nanoparticles: Characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes. J Mycol Med. 2020;30(3):101003.","journal-title":"J Mycol Med"},{"issue":"Suppl 1","key":"3070_CR50","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.4103\/jpbs.jpbs_463_22","volume":"15","author":"SD Dutta","year":"2023","unstructured":"Dutta SD. Determination of antifungal effect of natural oil and synthetic gutta percha solvents against candida albicans: a disc diffusion assay. J Pharm Bioallied Sci. 2023;15(Suppl 1):S235\u20138.","journal-title":"J Pharm Bioallied Sci"},{"issue":"1","key":"3070_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/1040841X.2020.1843400","volume":"47","author":"NO Ponde","year":"2021","unstructured":"Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP. Candida albicans biofilms and polymicrobial interactions. Crit Rev Microbiol. 2021;47(1):91\u2013111.","journal-title":"Crit Rev Microbiol"},{"issue":"7","key":"3070_CR52","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/jof9070753","volume":"9","author":"RA Coelho","year":"2023","unstructured":"Coelho RA, Figueiredo-Carvalho MH, Almeida-Silva F, de Souza Rabello VB, de Souza GR, Sangenito LS, et al. Repurposing benzimidazoles against causative agents of chromoblastomycosis: albendazole has superior in vitro activity than mebendazole and thiabendazole. J Fungi. 2023;9(7):753.","journal-title":"J Fungi"},{"issue":"4","key":"3070_CR53","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/mmy\/myaa058","volume":"59","author":"A Thakre","year":"2021","unstructured":"Thakre A, Jadhav V, Kazi R, Shelar A, Patil R, Kharat K, et al. Oxidative stress induced by piperine leads to apoptosis in Candida albicans. Med Mycol. 2021;59(4):366\u201378.","journal-title":"Med Mycol"},{"key":"3070_CR54","doi-asserted-by":"publisher","first-page":"741493","DOI":"10.3389\/fmicb.2021.741493","volume":"12","author":"I Ahamad","year":"2021","unstructured":"Ahamad I, Bano F, Anwer R, Srivastava P, Kumar R, Fatma T. Antibiofilm activities of biogenic silver nanoparticles against Candida albicans. Front Microbiol. 2021;12:741493.","journal-title":"Front Microbiol"},{"issue":"2","key":"3070_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/1348-0421.12668","volume":"63","author":"Y Matsumoto","year":"2019","unstructured":"Matsumoto Y, Sekimizu K. Silkworm as an experimental animal for research on fungal infections. Microbiol Immunol. 2019;63(2):41\u201350.","journal-title":"Microbiol Immunol"},{"key":"3070_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fmicb.2017.00373","volume":"8","author":"S Panthee","year":"2017","unstructured":"Panthee S, Paudel A, Hamamoto H, Sekimizu K. Advantages of the silkworm as an animal model for developing novel antimicrobial agents. Front Microbiol. 2017;8:373.","journal-title":"Front Microbiol"},{"issue":"1","key":"3070_CR57","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2672.2011.05186.x","volume":"112","author":"Y Matsumoto","year":"2012","unstructured":"Matsumoto Y, Miyazaki S, Fukunaga DH, Shimizu K, Kawamoto S, Sekimizu K. Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans. J Appl Microbiol. 2012;112(1):138\u201346.","journal-title":"J Appl Microbiol"},{"issue":"6","key":"3070_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/antibiotics9060300","volume":"9","author":"A Montali","year":"2020","unstructured":"Montali A, Berini F, Brivio MF, Mastore M, Saviane A, Cappellozza S, et al. A silkworm infection model for in vivo study of glycopeptide antibiotics. Antibiotics (Basel). 2020;9(6):300.","journal-title":"Antibiotics (Basel)."},{"issue":"1","key":"3070_CR59","doi-asserted-by":"publisher","first-page":"12289","DOI":"10.1038\/s41598-017-12523-z","volume":"7","author":"M Ishii","year":"2017","unstructured":"Ishii M, Matsumoto Y, Yamada T, Abe S, Sekimizu K. An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis. Sci Rep. 2017;7(1):12289.","journal-title":"Sci Rep"},{"issue":"4","key":"3070_CR60","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.3314\/mmj.17.016","volume":"58","author":"Y Matsumoto","year":"2017","unstructured":"Matsumoto Y, Ishii M, Shimizu K, Kawamoto S, Sekimizu K. A silkworm infection model to evaluate antifungal drugs for cryptococcosis. Med Mycol J. 2017;58(4):E131\u20137.","journal-title":"Med Mycol J"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03070-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03070-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03070-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T18:03:17Z","timestamp":1748541797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03070-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3070"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03070-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest related to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"77"}}